Fierce Pharma

JUNE 25, 2024

On the market for three years in China, Novo Nordisk’s diabetes drug Ozempic (semaglutide) is racing toward blockbuster sales in the world’s second most populous country. | China’s National Medical Products Administration (NMPA) has blessed Novo Nordisk's Wegovy with marketing approval to treat people with a body mass index (BMI) of at least 30 or between 27 and 30 for those with one weight-related risk factor.

Sales 304

Sales Marketing Medical 304

David Bagga

JUNE 25, 2024

Medical Device Sales Academy How to Increase Sales in a Medical Field Here are some of the ways that contribute towards increasing medical sales: 1. Get in-depth Product Knowledge A thorough understanding of your products is crucial in medical deals. This includes the technical specifications, clinical applications, and benefits. Attend training sessions, read product manuals, […] The post How to Increase Sales in a Medical Field appeared first on.

Medical 130

Medical Sales Product Knowledge Medical sales 130

Fierce Pharma

JUNE 25, 2024

In the U.S. Federal Trade Commission’s (FTC) latest campaign against what the agency views as “junk” drug patents listed at the FDA, drugmakers have decided not to play ball. | In the U.S. Federal Trade Commission’s latest campaign against what the agency views as “junk” drug patent listings in the FDA’s database, drugmakers have decided not to play ball.

FDA 297

FDA Pharma 297

Dominic Tyer

JUNE 25, 2024

Customer experience (CX) is not a new discipline for pharma, but it does continue to provide the industry with growing pains

Pharma 130

Pharma Consulting Marketing 130

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JUNE 25, 2024

With an agreement to make payments totaling $750 million over the next five years, Teva can wipe its slate clean of litigation from Israeli regulators that concerns over a decade's worth of taxes.< | The deal with the Israel Tax Authority wraps up pending litigation over taxes payable from 2008 to 2020. Crucially, Teva also has to pay additional taxes on any equity dividends or share repurchases.

296

296

Pharmaceutical Technology

JUNE 25, 2024

Novavax has sought EMA approval for its updated JN.1 Covid-19 vaccine, NVX-CoV2705, for people aged 12 years and above.

128

128

MedCity News

JUNE 25, 2024

Liquid biopsy company Grail is now an independent, publicly traded company. While the separation from Illumina ends a protracted antitrust battle, Grail is still in the early stages of a long-term strategy to win regulatory validation and payor coverage for its multi-cancer early detection test. The post Illumina Spin-Off Now Complete, Grail Sets Out on Its Own on the Public Markets appeared first on MedCity News.

Marketing 122

Marketing Biopharma 122

Fierce Pharma

JUNE 25, 2024

While patients with low potassium often need medication to boost levels of the electrolyte in the body, too much of a good thing can cause serious health concerns. | Glenmark Pharmaceuticals on Tuesday said it’s recalling 114 batches of 750mg potassium chloride extended-release capsules thanks to failed dissolution of the product. Failed dissolution of the capsules could cause patients to develop heightened potassium levels, also known as hyperkalemia, which can result in irregular heartbeat.

Side effects 281

Side effects Leads Medical Pharmaceutical 281

MedCity News

JUNE 25, 2024

Pomelo Care’s $46 million Series B funding round was led by existing investors First Round Capital and a16z and included participation from Stripes, Box Group, Operator Partners and SV Angel. The post Pomelo Care Secures $46M To Increase Access to Maternal Health appeared first on MedCity News.

114

114

Fierce Pharma

JUNE 25, 2024

AstraZeneca’s Imfinzi can’t have it all. | While the PD-L1 inhibitor posted a clinical win in muscle-invasive bladder cancer, it also chalked up a failure in early-stage non-small cell lung cancer.

200

200

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JUNE 25, 2024

Managed long-term services and supports (MLTSS) are emerging as essential lifelines for transformation. The post Empowering Independence: The Rising Role of MLTSS in Medicaid Evolution appeared first on MedCity News.

Management 114

Management 114

Fierce Pharma

JUNE 25, 2024

As other immunology players make inroads into the giant cell arteritis (GCA) arena, one of Johnson & Johnson’s top-grossing medicines, Tremfya, has come up short in the disease. | As other immunology players make inroads into the giant cell arteritis arena, one of Johnson & Johnson’s top-grossing medicines, Tremfya, has come up short in the disease.

Medicine 185

Medicine 185

PharmaVoice

JUNE 25, 2024

The FDA isn’t slated to render a decision about BMS and Karuna’s potential breakthrough schizophrenia med until September — but a biotech is already hoping to be hot on its heels.

FDA 114

FDA 114

MedCity News

JUNE 25, 2024

Knowing where healthcare professionals are online, their preferred platforms, and what they do there is crucial for pharma marketers. The post Decoding the Digital Footprint of Healthcare Professionals: A Roadmap for Pharma Marketers appeared first on MedCity News.

Healthcare 114

Healthcare Healthcare Marketing Pharma 114

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

JUNE 25, 2024

The European Commission has approved the first twice-yearly injection for relapsing and primary progressive multiple sclerosis (RMS and PPMS). Roche highlighted that as a 10-minute injection, OCREVUS ® (ocrelizumab) subcutaneous has the same twice-yearly schedule as the intravenous (IV) infusion, which was the first therapeutic to be approved for both RMS and PPMS.

Medicine 111

Medicine Safety Medical Pharmaceutical 111

MedCity News

JUNE 25, 2024

Function Health, a membership-based platform that gives consumers access to more than 100 different lab tests, closed a Series A financing round that brought its total funding to date to $53 million. The round was led by Andreessen Horowitz and included a slew of celebrity investors, including Matt Damon, Zac Efron, Blake Griffin and Colin Kaepernick.

111

111

PharmaVoice

JUNE 25, 2024

A COVID and flu duo could ease manufacturing and administration, potentially driving higher vaccination rates, said Moderna’s VP of North American medical affairs.

Manufacturing 110

Manufacturing Medical 110

pharmaphorum

JUNE 25, 2024

A survey of pharma industry executives has found that a third of them believe mistrust in the healthcare system has become a significant barrier to getting a diverse range of people to sign up for clinical trials.

Healthcare 108

Healthcare Healthcare Pharma 108

Advertisement

Pharmaceutical Commerce

JUNE 25, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Medicine Manufacturing 105

pharmaphorum

JUNE 25, 2024

Almost half of young adults who participated in a UK survey said they had made a health decision they regret based on misinformation

105

105

Pharmaceutical Technology

JUNE 25, 2024

Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to construct a second fill and finishing facility in Clayton.

Manufacturing 98

Manufacturing 98

pharmaphorum

JUNE 25, 2024

Oral ketamine from Douglas Pharma shows efficacy in phase 2 treatment-resistant depression trial and will move into pivotal trials

Pharma 105

Pharma 105

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

JUNE 25, 2024

Merck’s decision follows the independent committee's analysis that the trial is unlikely to meet its primary endpoints.

98

98

pharmaphorum

JUNE 25, 2024

AstraZeneca’s hopes of positioning Imfinzi as a post-surgery therapy for people with early-stage NSCLC have taken a knock

104

104

PharmaTimes

JUNE 25, 2024

Atherosclerotic plaques in the arteries affect 42% of adults living without heart disease

Medical 76

Medical 76

pharmaphorum

JUNE 25, 2024

Two years ago, Merck KgAA was talking up xevinapant as a leap forward in head and neck cancer and one of the brightest stars in its late-stage pipeline, Now, the drug has been abandoned after failing a phase 3 trial.The TrilynX study was testing xevinapant with chemoradiotherapy in patients with unresected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN), but according to an interim look at the data was unlikely to meet its goal of extending event-free survival.

Patients 103

Patients 103

Advertisement

Distribution

PharmaTech

JUNE 25, 2024

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

69

69

pharmaphorum

JUNE 25, 2024

In a new episode of the pharmaphorum podcast - recorded back in March, during Women’s History Month - web editor Nicole Raleigh spoke with Johan van Hylckama Vlieg, co-founder and chief scientific officer of Freya Biosciences, a Series A-financed, clinical stage, microbial immunotherapy company in women’s health, discussing the role of the vaginal microbiome in fertility, before he was due to speak at the first-of-its-kind Microbes in Women’s Health Congress in Copenhagen.

103

103

PharmaTimes

JUNE 25, 2024

An estimated 27% of patients globally living with diabetes will be affected by retinopathy

Patients 66

Patients 66

Pharmacy Times

JUNE 25, 2024

The recent approval could further the use of mRNA technology across other indications.

55

55

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales